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A sweetener with many names — Indian muscovado, Mexican 
piloncillo, African and Asian jaggery, and Colombian panela — this 
unrefined, non-centrifugal cane sugar has been a staple product across the 
world for centuries.1 No country’s constituents appreciate this delicacy 
 
            *     Associate Member, UNIVERSITY OF CINCINNATI LAW REVIEW 
 1.  J. Kenji López-Alt, Making Panela at a Colombian Sugar Mill is Still a Low-Tech Affair, 
SERIOUS EATS (Aug. 10, 2018), https://www.seriouseats.com/2015/01/making-panela-colombian-sugar-
mill-low-tech.html. 
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more than those of Colombia.2 Colombia is the runner-up in global panela 
production and the world leader in panela consumption per capita.3 On 
average, each Colombian citizen consumes over seventy pounds of panela 
each year.4 Beyond its use in cakes, pastries, and coffees, Colombians 
dissolve panela in hot water to create aguapanela.5 Served hot or cold, 
often with lime, aguapanela is a significant source of calories for working 
Colombians.6 Additionally, aguapanela mixed with ginger is used for 
medicinal purposes because of the purported health benefits of its trace 
vitamins and minerals, which are byproducts of panela’s crude production 
method.7 
In 2020, the United States Patent and Trademark Office (the “USPTO”) 
issued U.S. Patent No. 10,632,167 (“the ‘167 Patent”) for producing 
policosanol-rich sugarcane juice, which looks to capitalize on panela’s 
purported health benefits.8 To produce that juice, the ‘167 Patent 
describes a production method that closely resembles traditional methods 
used to make panela.9 Because patents grant their owners exclusionary 
rights over the practices claimed by the patent, Colombian panela 
producers are concerned that the ‘167 patent will upend their way of life.10 
This Comment analyzes the validity of the ‘167 patent and its potential 
impact on the Colombian panela industry. Part II provides an overview of 
the Colombian panela industry, the U.S. patent law system, relevant 
Colombian law, and the ‘167 Patent. Although Colombian patent law is 
discussed, this Comment primarily focuses on the U.S. patent law system. 
Part III discusses why the ‘167 Patent would likely be upheld if its validity 
was challenged in a court of law and, if upheld, why the ‘167 Patent may 
not affect Colombian panela producers. Finally, Part IV emphasizes the 
limits of the patent system and the importance of having a sound scientific 
basis when filing an application for patent. 
II. BACKGROUND 
Patent litigation is one of the most expensive types of litigation because 
 
 2.  Id. 
 3.  Id. 
 4.  Kirsten Begg, Aguapanela: The Truth, COLOMBIA REPS. (Mar. 12, 2009), 
https://colombiareports.com/aguapanela/. 
 5.  Jennie Erin Smith, Colombians Ask: Who Would Dare Patent Panela?, N.Y. TIMES (Jan. 26, 
2021), https://www.nytimes.com/2021/01/26/science/colombia-panela-patent-gonzalez.html. 
 6.  Id. 
 7.  Id. 
 8.  Id. 
 9.  Id. 
 10.  Id. 
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there are so many layers to each case.11 The current issue is no exception. 
Determining whether Colombian panela production would infringe the 
‘167 Patent requires analysis of Colombian panela’s deep-rooted, 
traditional method of production as well as the intricacies of U.S. patent 
law and overlapping international and foreign law. First, Section A of this 
Part discusses panela’s significance to Colombians and its traditional 
method of production. Second, Section B provides a brief overview of the 
U.S. patent system. Third, Section C summarizes Colombian patent law 
and other Colombian laws relevant to panela production. Finally, Section 
D walks through the ‘167 Patent and its controversial scientific 
foundations.  
A. The Significance and Production of Panela 
Panela is more than a diet staple to Colombians; it’s an irreplaceable 
source of income.12 The panela industry makes up nearly twelve percent 
of the Colombian workforce and is one of the main sources of income for 
more than 70,000 Colombian families.13 Through both its direct and 
indirect impact, the panela industry affects 350,000 Colombians and 
accounts for approximately 6.7% of Colombia’s agricultural gross 
domestic product.14 Further, it is estimated that over 98% of Colombian 
panela is consumed domestically, with only around 0.4% exported and 
the remaining used as input for industrial processes.15 
The process of making panela has gone essentially unchanged since 
sugarcane was first brought to South America in the sixteenth century.16 
That process begins in one of the over 200,000 hectares of Colombian 
sugarcane fields.17 Couriers, or cutters, chop down mature sugar cane 
stalks by hand.18 A carguero19 then stacks the chopped stalks onto the 
backs of donkeys and mules and accompanies it back to the trapiche20 
 
 11.  JANICE M. MUELLER, PATENT LAW 30 (Rachel E. Barkow et al. eds., 6th ed. 2020). 
 12.  Gonzalo Rodriguez et al., Panela Production as a Strategy for Diversifying Incomes in Rural 
Area of Latin America, FOOD AND AGRICULTURE ORGANIZATION OF THE UNITED NATIONS [FAO] 
(2007), https://www.fao.org/3/ap307e/ap307e.pdf. 
 13. Id. 
 14. Id. 
 15. Id. 
 16.  Dennis Bejarano, Panela’s Bitter Future, SLOW FOOD (July 23, 2015), 
https://www.slowfood.com/panelas-bitter-future. 
 17.  Begg, supra note 4. 
 18.  Smith, supra note 5. 
 19.  A carguero, or freighter, is an “operator who lifts and accompanies the sugarcane in the 
transport, which takes it from the batch to the sugar mill, generally it is done on the mules and the sugar 
cane from the sugar mill to the loading point.” Carguero, PANELERO INFO. SYS. (Apr. 2, 2019), 
http://www.sipa.org.co/wp/index.php/glossary/carguero/. 
 20.  A trapiche is the place “where sugarcane is processed to turn it into honey or panela.” Trapiche 
3
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where the panela is made.21 Most trapiches build a stockpile of chopped 
stalks for two weeks while workers are hired.22  
First, the raw sugarcane stalks are processed through hand and water-
powered mechanical rollers which grind those stalks into a juice.23 These 
hand and water powered rollers are a departure from using mules to power 
the rollers, a historic practice banned by the Colombian government for 
sanitation purposes.24 Next, the juice from the sugarcane stalks streams 
down into a series of large heated pans.25 The pans are heated by a furnace 
fueled with bagasse, the dried carcasses of grinded stalks.26 As the raw 
sugarcane juice is heated, workers add a wood pulp to the liquid to 
separate impurities from the juice.27 Once the juice begins to boil, workers 
use massive ladles to skim the surface of the juice and then transfer it to 
a heating vessel.28 With each transition, the sugarcane juice reduces, 
ferments, thickens, and darkens.29 There is no scientific determination 
that the sugar has been sufficiently heated or reached the appropriate 
sugar density; a worker may dip a stick in the heated syrup and cool it in 
cold water or check it with a wet, bare hand.30 
The final steps for processing the juice vary from trapiche to trapiche 
depending on the final product. In one method, the hot syrup-like solution 
is poured into molds and left to cool and harden.31 Common mold shapes 
include rectangular blocks and cones.32 Another method produces a patty-
shaped product. After transferring the thickened, nearly crystalized syrup 
to a final surface, workers begin to stir the product vigorously for 
cooling.33 A pesador34 then packs the cooling sugar into evenly sized 
patties. Once the patties fully cool, they begin to harden and are often 
stamped with the label for eventual sale.35 
 
panelero, PANELERO INFO. SYS. (Mar. 20, 2019), http://www.sipa.org.co/wp/index.php/glossary/trapiche-
panelero/. 
 21.  Smith, supra note 5. 
 22.  Id. 
 23.  Id. 
 24.  Lopez-Alt, supra note 1 
 25.  Id. 
 26.  Id. 
 27.  Smith, supra note 5. 
 28.  Id. 
 29.  Lopez-Alt, supra note 1. 
 30.  Smith, supra note 5. 
 31.  Gaston Rings, Process of making panela, trapiche in Colombia, YOUTUBE (Aug. 24, 2009), 
https://www.youtube.com/watch?v=1K6XKadWWq8. 
 32.  Smith, supra note 5. 
 33.  Lopez-Alt, supra note 1. 
 34.  Pesadors are trapiche workers that hand-weigh and shape hot panela into portions at the end 
of production. Smith, supra note 5. 
 35.  Lopez-Alt, supra note 1. 
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Because these trapiches provide so many jobs for Colombians, 
Colombia issued Law 40 of 1990 (“Law 40”) to regulate the production 
and exportation of panela.36 First, Law 40 outlawed large sugar 
corporations from producing panela in Colombia by limiting panela 
establishments to a grinding capacity of ten tons per hour.37 Second, Law 
40 allowed the government to regulate the conditions and quantities in 
which panela is produced.38 Additionally, Law 40 required that 
commercial panela producers register with the government and all 
exported panela be government-approved to guarantee the quality of the 
product.39 Lastly, Law 40 set out specific production, health, and quality 
standards that all panela must meet.40 
Despite some mechanical improvements to panela production, most 
trapiches operate a very traditional operation.41 Although some producers 
have been able to purchase upgrades like automobiles for sugarcane 
transport, high efficiency cane rollers, or closed tanks for evaporation, 
such machines are too expensive for most trapiche owners.42 Regardless, 
the ‘167 Patent may jeopardize both traditional and industrial panela 
producers.43 Because the process for producing panela, industrialized or 
not, consists of the same fundamental steps, the exclusionary rights 
granted by the ‘167 Patent could spell out disaster for Colombian panela 
producers.44 
B. Introduction to United States Patent Law 
Before an analysis can be done on the potential impact and viability of 
the ‘167 Patent, a basic understanding of U.S. patent law is necessary.45 
The following Subsections overview patents generally, the major tenants 
of patentability applied by the USPTO and U.S. courts, and the judicial 
approach to assessing patent infringement. 
 
 36.  L. 40, diciembre 4, 1990, DIARIO OFICIAL [D.O.] (Colom.) [hereinafter Law 40]. 
 37.  Id. 
 38.  Id. 
 39.  Id. “It will be understood that the panelero establishment is of a commercial nature when its 
production exceeds the amount of one tonne per week” Id. 
 40.  Id. 
 41.  Lopez-Atl, supra note 1. 
 42.  Id.; Alcaldia Obando, BIOBANDO, YOUTUBE (Sept. 8, 2012), 
https://www.youtube.com/watch?v=LYQlV4htOdg. 
 43.  Smith, supra note 5. 
 44.  Id. 
 45.  This is not intended to be a comprehensive guide to U.S. patent law. Only a basic overview 
of the major tenants of patentability is provided. 
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1. Patent Overview 
Patents are a form of intellectual property geared towards scientific 
discoveries, inventions, and processes.46 Like copyrights, trademarks, and 
trade secrets, patents confer certain intangible rights to their owners.47 
These rights are secured by the Patent and Copyright Clause of Article I 
of the U.S. Constitution, which states that “[t]he Congress shall have 
Power…[t]o promote the Progress of Science and useful Arts, by securing 
for limited Times to Authors and Inventors the exclusive Right to their 
respective Writings and Discoveries.”48 In other words, the Patent and 
Copyright Clause implies exclusionary rights to inventors and authors to 
incentivize innovation and creativity.49  
The exclusionary rights that accompany an issued patent allow the 
patent’s owner to prevent others from making, using, offering to sell, 
selling, or importing that patented invention throughout or into the United 
States.50 By offering avenues for protection and exclusivity for their 
works, innovators are financially motivated to create.51 The government 
only offers these exclusionary rights for a limited time and requires full 
disclosure of the invention at the time of application for patent.52 The 
government limits exclusionary rights to ensure the public benefits from 
the disclosure of new technologies even if the inventor decides not to put 
their invention on the market.53 Once a patent’s limited window of 
protection expires, the public is free to make, use, sell, and import the 
expired patent’s claimed invention or method.54  Further, patents and 
patent applications are published and made available to the public, 
ensuring the dissemination of their knowledge and fueling future 
innovation.55 
2. Statutory Patentability Requirements 
 Before inventors are granted exclusivity rights in the U.S. over their 
 
 46.  MUELLER, supra note 11, at 8. 
 47.  Id. 
 48.  U.S. Const. art I, § 8, cl. 8. 
 49.  Id. 
 50.  35 U.S.C. § 271(a) (2012). 
 51.  MUELLER, supra note 11, at 31. 
 52.  Id. A newly issued U.S. patent is valid for at least twenty years from the date of its earliest 
effective filing date in the U.S. Patent and Trademark Office. Applications that face undue delay in their 
prosecution process might qualify to have their terms extended. 35 U.S.C. § 154 (2019). 
 53. MUELLER, supra note 11, at 31. 
 54. Id. 
 55. Id. at 73-76. 
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invention, they must file a patent application with the USPTO.56 Patent 
applications must fully disclose the invention such that someone having 
ordinary skill in the art would be able to use the claimed invention.57 Once 
prepared and filed, the application goes through a process called patent 
prosecution where the USPTO evaluates the application and determines 
whether the invention is patentable.58 The determination of patentability 
revolves around three main requirements: (1) utility; (2) novelty; and (3) 
non-obviousness.59 
The first requirement of patentability is utility.60 For an invention to be 
useful, or have utility, it need only cross a very low threshold.61 If the 
invention is “capable of providing some identifiable benefit,” then it is 
useful under the law.62 Despite that low bar, utility is still necessary. For 
example, in Brenner v. Manson, the United States Supreme Court 
considered a chemist’s patent application for a steroid that claimed to 
have tumor-inhibiting effects in mice.63 However, the applicant based 
these claims entirely on the steroid’s similar make-up to another 
compound which had actually demonstrated tumor inhibiting effects.64 
The Court agreed with the USPTO and rejected the chemist’s patent 
application for lack of utility, holding that being similar to a separate 
useful invention does not prove utility.65 For the government to grant 
exclusivity rights, an inventor must disclose a legitimate use for his 
invention, not merely allude to some potential use for someone else to 
discover.66 Additionally, Brenner laid the ground work for the “specific, 
substantial, and credible” standard of patent utility.67 Patent examiners are 
told not to impose utility rejections “if the applicant has asserted that the 
claimed invention is useful for any particular practical purpose (i.e., it has 
a ‘specific and substantial utility’) and the assertion would be considered 
credible by a person of ordinary skill in the art.”68 
 
 56.  Id. at 12. 
 57.  35 U.S.C. § 112(a) (2019). 
 58.  MUELLER, supra note 11, at 66. 
 59.  MUELLER, supra note 11, at 67. 
 60.  35 U.S.C. § 101(a) (2019). 
 61.  Juicy Whip, Inc. v. Orange Bang, Inc., 185 F.3d 1364, 1366 (Fed. Cir. 1999). 
 62.  Id. 
 63.  383 U.S. 519, 522 (1966). 
 64.  Id. 
 65.  Id. at 535. 
 66.  Id. This also leans towards another factor, enablement, that is not an issue here regarding 
panela. 35 U.S.C. § 112(a) (2019). 
 67.  Brenner, 383 U.S. at 534-535. 
 68.  MPEP (9th ed., June 2020) § 2107(II)(A)(3). “Credibility is assessed from the perspective of 
one of ordinary skill in the art in view of the disclosure and any other evidence of record (e.g., test data, 
affidavits or declarations from experts in the art, patents or printed publications) that is probative of 
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The second requirement for patentability is novelty.69 The Leahy-
Smith America Invents Act of 2011 simplified the basic principles of 
novelty: if a claimed invention has been “patented, described in a printed 
publication, or in public use, on sale, or otherwise available to the public 
before the effective filing date of the claimed invention” anywhere in the 
world, then the claimed invention is considered to be anticipated and 
therefore not patentable.70 Further, for an invention to be anticipated, it 
must be described in its entirety by the earlier filed patent, patent 
application, or printed publication (collectively, “prior art”); this is known 
as the strict identity standard.71 For example, in Titanium Metals Corp. v. 
Banner, employees of Titanium Metals Corporation of America 
(“Titanium”) developed a titanium alloy and received a patent on the 
invention.72 The patent claimed a “titanium [(Ti)] base alloy consisting 
essentially by weight of about 0.6% to 0.9% nickel [(Ni)], 0.2% to 0.4% 
molybdenum [(Mo)], up to 0.2% maximum iron, balance titanium.”73 
Five years earlier, however, an article had been published in a Russian 
journal featuring a data point corresponding to a Ti-Ni-Mo alloy 
consisting of 0.75% Ni and 0.25% Mo.74 When the Titanium patent’s 
validity was challenged, the United States Court of Appeals for the 
Federal Circuit held that the patent was wrongly issued because it was 
anticipated by the alloy disclosed in the Russian journal article and 
therefore unpatentable for lack of novelty.75 Alternatively, if the alloy 
disclosed in the Russian journal article instead comprised of only 0.4% 
Ni or 0.5% Mo, Titanium’s alloy would not have satisfied the strict 
identity standard and would have qualified as novel over the previously 
disclosed alloy.76 
The third requirement for patentability is non-obviousness.77 Non-
obviousness bars an invention from being a mere variation or combination 
of prior art that “would have been obvious to a person having ordinary 
skill in the art” (“PHOSITA”).78 PHOSITAs are afforded a certain degree 
of creativity within their fields; as a result, the USPTO commonly rejects 
 
the applicant’s assertions. An applicant need only provide one credible assertion of specific and 
substantial utility for each claimed invention to satisfy the utility requirement.” Id. § 2107(II)(B)(1)(ii). 
 69.  MUELLER, supra note 11, at 67.  
 70.  35 U.S.C. § 102(a) (2019). 
 71.  MUELLER, supra note 11, at 242. 
 72.  778 F.2d 775, 776 (Fed. Cir. 1985). 
 73.  Id. 
 74.  Id. 
 75.  Id. at 782. The “up to 0.2% maximum iron” limitation in Titanium’s claim is interpreted as 
including 0% iron. Thus, the strict identity standard was satisfied even though the Russian alloy did not 
include iron. Id. 
 76.  Id. at 781. 
 77.  MUELLER, supra note 11, at 67. 
 78.  35 U.S.C. § 103 (2019). 
8
University of Cincinnati Law Review, Vol. 90, Iss. 2 [], Art. 8
https://scholarship.law.uc.edu/uclr/vol90/iss2/8
2021] TRICK OR TREAT? 673 
the following for being obvious: (1) combinations of analogous prior art; 
(2) substitutions of elements in a piece of prior art; and (3) situations in 
which there are only a limited number of possible solutions to a 
problem.79 The following is a classic example of obviousness:80  
A is known in the prior art, and B is known in the prior art. Upon looking 
at A and then looking at B, would [a PHOSITA] consider A+B to be 
already known? If the answer is yes, then A+B is obvious. If the answer is 
no, then A+B is not obvious.81 
 A fourth and less common requirement for patentability is that a patent 
applicant may only be granted a single U.S. patent on a given invention.82 
This requirement only pertains to inventors with at least one other pending 
U.S. application or granted U.S. patent.83 If a patent applicant attempts to 
receive a second patent over his already patented invention, the USPTO 
will issue a “double patenting” rejection.84  
There are two types of double patenting rejections.85 First, a same 
invention-type double patenting rejection is when a later-filed application 
claims the exact same scope as the applicant’s original patent or 
application.86 Second, an obviousness-type double patenting rejection 
exists when the later-filed application claims “a merely obvious variant” 
of the applicant’s original patent or application.87 Double patenting 
rejections are issued by the USPTO and U.S. courts to prevent parties 
from unjustifiably extending monopolies over already-patented products 
or processes.88 Applicants often attempt to circumvent the “one patent per 
invention” rule by obtaining patents on products used to produce the 
already patented invention or by obtaining patents on new uses, 
formulations, or preparations of the invention.89 
3. Patent Infringement 
As mentioned above, a patent grants its owner the right to exclude 
 
 79.  KSR Int'l Co. v. Teleflex Inc., 550 U.S. 398, 400-403 (2007). 
 80.  Gene Quinn, Patentability: The Nonobviousness Requirement of 35 U.S.C. 103, IP 
WATCHDOG (June 17, 2017), https://www.ipwatchdog.com/2017/06/17/patentability-nonobviousness-
35-usc-103/id=84716/. 
 81.  Id. 
 82.  MUELLER, supra note 11, at 82. 
 83.  Id. 
 84.  Id. 
 85.  Id. 
 86.  Id. 
 87.  Id. 
 88.  Id. at 83. 
 89.  Id. at 82 n. 264. 
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others from making, selling, using, or importing the patented invention.90 
When a person violates those rights, it is called patent infringement.91 A 
person can either infringe literally or under the doctrine of equivalents.92 
Literal infringement is when a defendant’s actions fall directly within the 
bounds of a patent’s claims.93 For example, in Titanium Metals Corp. v. 
Banner, Titanium’s patent was anticipated by the Ti-Ni-Mo alloy 
(containing 0.75% Ni and 0.25% Mo) disclosed in the Russian journal 
article.94 If the article had never been published and Titanium’s patent 
issued, a competitor who subsequently produced the disclosed alloy 
would be held liable for literal infringement because the produced alloy 
would fall squarely within the ranges claimed by Titanium’s patent.95 To 
illustrate further, if in that same scenario the competitor’s alloy had 
comprised only 0.59% Ni and 0.41% Mo, then the competitor would not 
be held liable for literal infringement.96 The common law doctrine of 
equivalents addresses this loophole.97  
The doctrine of equivalents asks whether potential infringers’ actions 
“perform substantially the same function, in substantially the same way, 
to achieve the same result”; if so, then there is infringement.98 This is a 
fact-specific and unreliable inquiry.99 For example, if Titanium’s 
hypothetical competitor had produced the Ti-Ni-Mo alloy comprised of 
0.59% Ni and 0.41% Mo, then a court would have to determine whether 
the 0.01% composition changes would produce a substantially similar 
alloy.100 If the alloy satisfied the substantial similarity test, it would have 
been found to infringe under the doctrine of equivalents.101 But, if the 
0.01% composition changes had significantly altered a characteristic, 
such as the alloy’s conductivity or tensile strength, then it would have 
been unlikely to infringe under the doctrine of equivalents.102  
An accused patent infringer can generally raise two arguments to avoid 
penalty: (1) claim that the patent is actually invalid and should never have 
 
 90.  Id. at 735. 
 91.  35 U.S.C. § 271(a) (2019). 
 92.  MUELLER, supra note 11, at 735. 
 93.  Id. at 782. 
 94.  778 F.2d 775, 776 (Fed. Cir. 1985). 
 95.  Id. 
 96.  MUELLER, supra note 11, at 782. The ranges of the original Titanium patent were 0.6-0.9% 
Ni, 0.2-0.4% Mo, up to 0.2% Fe, balance Ti. Titanium Metals Corp. v. Banner, 778 F.2d at 776. 
 97.  Id. at 783 
 98.  Graver Tank & Mfg. Co. v. Linde Air Prod. Co., 339 U.S. 605, 608 (1950). 
 99.  MUELLER, supra note 11, at 787. 
 100.  Graver Tank & Mfg. Co. v. Linde Air Prod. Co., 339 U.S. at 608. 
 101.  Id. 
 102.  Id. 
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been issued; or (2) claim that they did not actually infringe.103 Claiming 
invalidity forces the court to reevaluate the patent with regard to the 
requirements of patentability.104 When the court reevaluates the validity 
of an issued patent, the defendant must overcome the patent’s 
presumption of validity.105 
 A defendant claiming that it did not actually infringe argues that its 
actions fall outside of the scope of the patent’s claims.106  Here, the court 
must interpret the scope of those claims and determine what the patent 
protects.107 Once the court has interpreted the patent, it determines 
whether the defendant’s actions fall within the scope of the claims.108 If 
the court finds that the defendant’s actions fall within the scope of the 
claims either literally or under the doctrine of equivalents, then there is 
infringement.109  
Alternatively, a defendant that has been performing the allegedly 
infringing activity since before the public disclosure of the issued patent 
may avail a third defense.110 Known as prior user rights, an accused 
infringer may continue its allegedly infringing activity if: (1) “such 
person, acting in good faith, commercially used the subject matter”; and 
(2) “such commercial use occurred at least 1 year before the earlier of 
either…the effective filing date of the claimed invention or the date on 
which the claimed invention was disclosed to the public.”111 If the court 
finds that these elements are satisfied, then the accused infringer will 
prevail.112  
C. Introduction to Colombian Patent Law 
The Colombian patent system operates on slightly different terms than 
its U.S. counterpart.113 Once a patent application is submitted to the 
Colombian Patent Office (“Division de Nuevas Creaciones”), the 
invention is evaluated for newness, inventive step, and industrial 
 
 103.  MUELLER, supra note 11, at 853. 
 104.  Id. 
 105.  Id. at 959. 
 106.  Id. at 750. 
 107.  Id. 
 108.  Id.  
 109.  Id. at 735. 
 110.  Id. at 860. 
 111.  35 U.S.C. § 273 (2015). 
 112.  MUELLER, supra note 11, at 861-862. 
 113.  Pamela Bechtel Hwang, Colombia: gateway to South America's Patent Prosecution Highway, 
DLA PIPER (Dec. 10, 2012), https://www.dlapiper.com/en/us/insights/publications/2012/12/colombia-
gateway-to-south-americas-patent-prosec__/. 
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applicability.114 
First, similar to the novelty requirement under U.S. patent law, a 
Colombian invention submitted for patent must be new and cannot have 
been made previously available to the public.115 Public availability 
includes any written or oral description, public use, sale, or offer for sale 
of the invention prior to the application’s priority date.116 Also like U.S. 
patent law’s novelty requirement, publicly disclosed information 
regarding the Colombian patent application must satisfy the strict identity 
standard, meaning prior art that does not describe the claimed invention 
in full cannot destroy novelty.117 
Second, similar to the non-obviousness requirement under U.S. patent 
law, a Colombian invention submitted for patent must demonstrate an 
inventive step.118 For an invention to be inventive in light of the prior art, 
it cannot be deemed “obvious or evidently derived from the prior art by a 
person ordinarily skilled in the art.”119 Further, inventive step is typically 
assessed according to a problem-solution approach.120 Under both the 
Colombian inventive step and U.S. non-obviousness standards, a patent 
rejected as obvious can be rebutted because of secondary 
considerations.121 Examples of secondary considerations include 
evidence of surprising results, economic success, a longstanding hole in 
the market, excessive experimentation, and prior art that teaches away 
from what the invention claims.122 
Third, similar to the utility requirement under U.S. law, a Colombian 
invention submitted for patent must have industrial applicability, which 
requires that the invention be capable of being “produced or used in any 
type of industry.”123 The term “industry” is defined as “involving any 
productive activity, including services.”124 The Colombian industrial 
applicability requirement is therefore nearly interchangeable with the 
 
 114.  U.S. COM. SERVICE, U.S. DEP’T COM., INTELLECTUAL PROPERTY RIGHTS TOOLKIT 
COLOMBIA (2011). 
 115.  CARLOS R. OLARTE ET AL., GETTING THE DEAL THROUGH – PATENTS 52 (Stuart J. Sinder 
eds., 10th ed., 2013). 
 116.  Id. 
 117.  Id.  
 118.  Id.  
 119.  Id. 
 120.  Id.  
 121.  Id.  
 122.  Id. “Teaching away” means that the piece of prior art suggests or requires an invention only 
work in a way opposite or contrary to that of the newly claimed invention. Id.  
 123.  Subregional Integration Agreement (Cartagena Agreement), Decision 486—Common 
Provisions on Industrial Property art. 19, Sept. 14, 2000, available at: https://www.wipo.int/edocs/lexdocs/ 
laws/en/can/can012en.pdf [hereinafter Decision 486]. 
 124.  Id.  
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U.S. utility requirement.125  
Ownership of a Colombian patent gives the owner the right to prevent 
third parties from manufacturing, selling, offering to sell, importing, and, 
in the case of a method claim, using the patented invention.126 Under 
Colombian law, for a party to infringe on a patent, it must do so 
literally.127 Unlike the U.S., Colombia runs on a civil law system.128 Civil 
law systems do not rely on case law; instead, courts lean heavily on 
statutes, codes, treaties, and other types of written laws.129 Because there 
is no written doctrine of equivalents in Colombian patent law, a patent 
owner cannot rely on the infringer’s actions being substantially similar to 
its patent to prevail on an infringement claim.130 A patent owner’s success 
in infringement actions therefore depends on whether courts interpret 
patent claims broadly enough to find literal infringement.131 
Prior user rights are also recognized in Colombia.132 A party qualifies 
for Colombian prior user rights if the party “in good faith and before the 
priority date or the filing date of the application on which the patent was 
granted, was already using or exploiting the invention, or had already 
made effective and serious preparations for such use or exploitation.”133 
Unlike its U.S. counterpart, Colombian prior user rights are not limited to 
those who practiced an issued patent more than one year prior to its 
disclosure.134 
D. The Claims and Prosecution History of Patent No. 10,632,167 
On April 28, 2020, the ‘167 Patent was issued to Jorge Enrique 
Gonzalez Ulloa (“Mr. Gonzalez”).135 The ‘167 Patent’s title, “System and 
method for processing raw sugarcane maximizing the preservation of 
policosanols during production of a shelf stable potable cholesterol-
reducing product,” is deceiving.136 At first glance, the patent merely 
discloses a process for manufacturing a pharmaceutical, but a closer 
 
 125.  FREDERICK M. ABBOTT ET AL., INTERNATIONAL INTELLECTUAL PROPERTY IN AN 
INTEGRATED WORLD ECONOMY 218 (Rachel E. Barkow et al. eds. 4th ed. 2019). 
 126.  Decision 486, supra note 123. 
 127.  Olarte, supra note 115, at 51. 
 128.  What is the Civil Law?, LSU LAW (last visited Apr. 17, 2021), https://www.law.lsu.edu 
/clo/civil-law-online/what-is-the-civil-law/. 
 129.  Id.  
 130.  Olarte, supra note 115, at 51. 
 131.  Id. 
 132.  Decision 486, supra note 123. 
 133.  Id. 
 134.  Id. 
 135.  U.S. Patent No. 10,632,167 (filed Nov. 3, 2017). 
 136.  Id. 
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examination reveals a strong resemblance to panela production.  
The ‘167 Patent claims a process for producing a policosanol-rich 
sugarcane juice product.137  Policosanol is an alcohol derived from the 
waxy part of plants that the ‘167 Patent claims is “an effective remedy for 
the treatment of unhealthy elevated blood cholesterol levels in 
humans.”138 But, the studies that support these alleged benefits were 
produced by a single research group whose results have since been 
unrepeatable.139 Moreover, the ‘167 Patent faced double-patenting and 
obviousness rejections during patent prosecution but was able to 
overcome the rejections by emphasizing its policosanol-centered 
disclosure.140 The following paragraphs explain policosanol and its 
uncertain standing in the scientific community, describe the process 
claimed by the ‘167 Patent, and breakdown the ‘167 Patent’s prosecution 
history.  
1. The Uncertainties of Policosanol 
In the early 2000’s, a Cuban research group released its findings on the 
therapeutic effects of a sugarcane wax-based policosanol supplement.141 
The Cuban research group’s findings showed that the supplement was an 
efficacious treatment for various cardiovascular-related ailments, 
particularly hypercholesterolemia.142 The research group claimed that a 
daily intake of the supplement lowered overall cholesterol levels by 
increasing the liver’s ability to process low-density lipoproteins (“LDL”) 
and decreasing HMG-CoA reductase activity.143 These findings were 
significant because the prescription medications normally used to treat 
high cholesterol can have harmful side effects.144 In contrast, the 
 
 137.  Id. 
 138.  Id. 
 139.  Christopher P. F. Marinangeli et. al, Policosanols as Nutraceuticals: Fact or Fiction, 
CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION, Mar. 2010, at 259. 
 140.  U.S. Patent No. 10,632,167 (filed Nov. 3, 2017), Non-Final Office Action dated May 21, 2019, 
p. 3, 5 [hereinafter Non-Final Office Action]. 
 141.  Marinangeli, supra note 139. 
 142.  Id. “Despite low bioavailability, numerous studies originating in Cuba have shown PC 
supplements to be efficacious treatments for various cardiovascular-related ailments including 
hypercholesterolemia, poor arterial function, poor antioxidant status, and intermittent claudication.” Id. at 
260. 
 143.  Id. LDL is commonly referred to as “bad cholesterol” and HMG-CoA reductase inhibitors 
make-up most common cholesterol lowering drugs. LDL and HDL Cholesterol: “Bad” and “Good” 
Cholesterol, CENTERS FOR DISEASE CONTROL AND PREVENTION (Jan. 31, 2020), 
https://www.cdc.gov/cholesterol/ldl_hdl.htm; Agam B. Bansal & Manouchkathe Cassagnol, HMG-CoA 
Reductase Inhibitors, NATIONAL CENTER FOR BIOTECHNOLOGY INFORMATION (Nov. 4, 2020), 
https://www.ncbi.nlm.nih.gov/books/NBK542212/. 
 144.  Marinangeli, supra note 139, at 265. 
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policosanol supplement presented zero adverse side effects.145 
Despite the promise of a natural and side-effect-free method of 
lowering cholesterol, the scientific community has met the Cuban studies 
with skepticism.146 This skepticism grew as researchers were unable to 
produce even mildly similar results to the original Cuban study.147 
Researchers outside Cuba attempted to recreate the original experiments, 
but not a single experiment showed significant changes in patients’ 
cholesterol levels.148 When the adverse findings were released, the 
original Cuban researchers claimed that the policosanol used in their 
study had “unique properties.”149 Interestingly, the Cuban group used a 
sugarcane-based supplement, whereas the external research groups used 
policosanols derived from plants other than sugarcane and prepared them 
with different methods.150 Despite those differences, the policosanols 
used by the external groups had purity levels and alcohol chain lengths 
similar to those of the original Cuban policosanol supplement.151 Further, 
the original Cuban supplement was later tested by a different research 
group and it presented no signs of lowering cholesterol.152 Ultimately, 
even though there are a number of studies that refute the results of the 
original Cuban research group, more research must be conducted before 
definitively stating that the original studies were falsified.153 
2. The Claims of U.S. Patent No. 10,632,167 
The ‘167 U.S. Patent claims a process of producing a policosanol-rich 
sugarcane juice.154 Trademarked in the U.S. as “Policane,” the product is 
intended to be a beverage for everyday consumption.155 Policane is 
comparable to Colombian aguapanela and the processes for producing 
them are nearly identical.156 
 The ‘167 Patent’s process begins with harvesting raw sugarcane by 
 
 145.  Id. 
 146.  Id. at 259. 
 147.  Id. at 260. 
 148.  Id.  
 149.  Id. at 260. 
 150.  Id. at 262. 
 151.  Id. 
 152.  Id.  
 153.  Id. at 265. 
 154.  U.S. Patent No. 10,632,167 (filed Nov. 3, 2017). 
 155.  Smith, supra note 5. 
 156.  Id.  
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hand.157 Next, the unwashed cane is chopped into small pieces.158 Then, 
the chopped cane is softened with cool water and juiced in a series of 
mechanical rollers at the lowest possible rate and a pressure of about 
1,500 pounds per square inch.159 The policosanol-rich juice is collected 
only from the first two rollers.160  
This policosanol-rich juice is then filtered to remove larger unwanted 
particles.161 Next, the pH and sugar density levels of the juice are managed 
in a series of clarification, heating, and inversion steps. First, calcium 
hydroxide is added to lower the pH level of the juice.162 Second, the juice 
is heated to no more than seventy degrees Celsius to preserve the 
policosanols.163 Flocculates are then added to the juice to collect 
impurities.164 These sink to the bottom of the vats and are vacuumed 
out.165 Bubbles are then pumped through the vat to push the flocculates to 
the top of the vat where the impurities are skimmed off the top.166 Finally, 
the juice is evaporated to increase its sugar density, the remaining syrup 
is inverted with citric or phosphoric acid to reduce the pH, and a sugar 
vacuum is used to once again increase the sugar density before it is left to 
cool.167  
3. The Prosecution History of U.S. Patent No. 10,632,167 
Like most other patent applications, the ‘167 Patent’s application was 
initially rejected by the USPTO and deemed unpatentable by an 
examiner.168 Patent prosecution allows for an applicant to make changes 
to an application or introduce arguments as to why the USPTO examiner 
should not have rejected the application.169 The ‘167 Patent’s application 
faced two rejections.170 The first rejection was an obviousness-type 
double patenting rejection related to a separate patent owned by Mr. 
Gonzalez, U.S. Patent No. 6,245,153 (“the ‘153 Patent”).171 The examiner 
 
 157.   U.S. Patent No. 10,632,167 (filed Nov. 3, 2017). Mechanical harvesting of sugarcane 
typically employs a burning mechanism which reduces policosanol levels. Id. 
 158.  Id. 
 159.  Id.  
 160.  Id. 
 161.  Id. 
 162.  Id. 
 163.  Id. 
 164.  Id. 
 165.  Id. 
 166.  Id. 
 167.  Id. 
 168.  Non-Final Office Action, supra note 140. 
 169.  MUELLER, supra note 11, at 68. 
 170.  Non-Final Office Action, supra note 140. 
 171.  Id. at 3. 
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also rejected the ‘167 Patent’s application as obvious over the ‘153 
Patent.172  
The ‘153 Patent disclosure is extremely similar to the ‘167 Patent’s 
disclosure.173 Titled “Method for producing sugar cane juice,” the ‘153 
Patent claims a process for producing juice from sugarcane stalks.174 The 
‘153 Patent process is nearly identical to the process claimed by the ‘167 
Patent’s application, except it takes no steps to preserve the policosanols 
in sugarcane stalks and does not even mention the compound.175 Further, 
the examiner stated that despite the ‘153 Patent failing to teach a 
policosanol-rich bagasse, the ‘153 Patent process “would inherently 
produce policosanol-rich bagasse” because similar stalks were passed 
through similar rollers in both processes.176 In conjunction with the shared 
inventorship between the ‘153 Patent and the ‘167 Patent’s application, 
these similarities led the examiner to make an obviousness-type double 
patenting rejection.177 
The obviousness rejection was supported with multiple references to 
the ‘153 Patent specification.178 These references point out the nearly 
identical juice extraction, filtration, heating, clarification, flocculation, 
and evaporation steps between the two claimed processes.179 In the 
absence of evidence to the contrary, the examiner found that the ‘167 
Patent’s application as a whole was obvious to a PHOSITA in light of the 
‘153 Patent.180 
Mr. Gonzalez successfully rebutted both rejections with a three-part 
argument focused on the preservation of policosanols.181 First, the ‘167 
Patent application called for specific limitations in the sugarcane juice 
production process explicitly designed to preserve policosanols.182 The 
steps mentioned by Mr. Gonzalez to preserve policosanols include: (1) 
not cleaning the cut cane stalks; (2) heating the pH-stabilized juice 
without reaching a temperature that would evaporate policosanols; and 
(3) filtering and re-adding the froth from the clarification step back into 
the juice.183 Second, the ‘153 Patent discloses steps that would destroy 
 
 172.  Id. at 5. 
 173.  U.S. Patent No. 6,245,153 (filed August 8, 1999). 
 174.  Id. 
 175.  Id. 
 176.  Non-Final Office Action, supra note 140, at 4. 
 177.  Id. at 3-4. 
 178.  Id. at 4-7. 
 179.  Id. at 5-6. 
 180.  Id. at 6-7. 
 181.  U.S. Patent No. 10,632,167 (filed Nov. 3, 2017), Amendment dated Nov. 21, 2019, p. 8, 11-
12 [hereinafter Amendment]. 
 182.  Id. at 8. 
 183.  Id. at 8-10. 
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policosanols, including the cleaning of the cut cane stalk, excessive 
heating of the juice, and removal of policosanol-rich froth.184 Lastly, Mr. 
Gonzalez argued that it took “over five years of continuous research and 
experimentation to arrive at a modified version of [the] original 
process.”185  
Ultimately, Mr. Gonzalez was successful in rebutting the examiner’s 
rejections and was granted the patent.186 Because of this, the ‘167 Patent 
would be given a presumption of validity if challenged in a court of law.187 
However, just because a patent is presumed valid does not mean it cannot 
be found invalid.188  
III. DISCUSSION 
Unfortunately, if the ‘167 Patent is challenged in an infringement 
lawsuit in the U.S., the court would likely deem it valid. This does not 
mean that Colombians should be concerned about their way of life being 
upended. First, Section A of this Part breaks down why the ‘167 Patent 
would likely be upheld. Second, Section B discusses why, regardless of 
its validity, the ‘167 Patent would not impact the Colombian panela 
industry.  
A. U.S. Patent Validity 
If challenged in a U.S. court of law, the ‘167 Patent’s validity would 
likely be upheld. Of the main U.S. criteria for patentability, a lack of 
utility presents the strongest argument for the ‘167 Patent’s invalidity. 
Although they would be weak, novelty and obviousness arguments can 
also be made against validity.  
The strongest argument against the ‘167 Patent’s validity is for lack of 
utility. Even though the utility threshold is low, all patentable inventions 
must be useful.189 The issue lies with the efficacy of policosanols. As 
shown through the ‘167 Patent’s prosecution history, the ‘167 Patent is 
only patentable over the ‘153 Patent because of the process changes it 
implements to preserve policosanols in the final juice product.190 Without 
these changes, the ‘167 Patent would be unpatentable for obviousness and 
 
 184.  Id. 
 185.  Id. at 8. 
 186.  U.S. Patent No. 10,632,167 (filed Nov. 3, 2017), Notice of Allowance dated Feb. 26, 2020, p. 
1 [hereinafter Notice of Allowance]. 
 187.  MUELLER, supra note 11, at 959. 
 188.  Id. 
 189.  Juicy Whip, Inc. v. Orange Bang, Inc., 185 F.3d 1364, 1366 (Fed. Cir. 1999). 
 190.  See Amendment, supra note 181, at 7-13; Notice of Allowance, supra note 186. 
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double patenting.191 Because the policosanols comprise the novel and 
non-obvious portion of the ‘167 Patent, it is the policosanols that must 
have utility; if there is no utility in the preservation of policosanols, then 
the only other utility is in producing a sugarcane juice product, a feat 
already accomplished by the ‘153 Patent.192 
There is little research and increased skepticism regarding the true 
effects of policosanols, especially the effects boasted by the ‘167 
Patent.193 According to the ‘167 Patent, policosanols are a side-effect-free 
alternative to blood cholesterol pharmaceuticals such as Lipitor, Crestor, 
and Lescol; it even claims that policosanols are just as, if not more, 
effective than these leading brands.194 The ‘167 Patent asserts that 
policosanols “are remarkably effective” in reducing a component of 
cholesterol known to cause a slew of health-related problems.195 The 
scientific community, however, is skeptical of policosanols’ purported 
health benefits because the original results indicating that policosanols are 
a miracle compound have been unrepeatable.196 
This unrepeatability implies that the utility of policosanols is not yet 
known. At the very least, the attempted recreations of the Cuban studies 
indicate that policosanols, outside of the exact conditions and preparation 
methods of those studies, have no proven utility.197 This situation can be 
equated to the Brenner case.198 Like the similar steroid homologues in 
Brenner, the policosanols derived by the ‘167 Patent will be of at least 
similar purity levels and alcohol chain lengths as the original Cuban 
policosanol supplements because of their shared sugarcane base.199 But, 
as determined in Brenner, similar chemical make-ups are not a sufficient 
basis for utility.200 Here, if the ‘167 Patent’s policosanols do not actually 
lower cholesterol, the true utility of the sugarcane juice is left to be 
discovered by someone else. Therefore, because the policosanols have no 
established utility, the issued patent would be invalid.201  
Unfortunately, even though there is no conclusive evidence of the ‘167 
Patent’s utility, the limited studies available are unlikely to overcome the 
‘167 Patent’s presumption of validity. With this presumption of validity 
 
 191.   See Amendment, supra note 181, at 7-13; Notice of Allowance, supra note 186; Non-Final 
Office Action, supra note 140, at 2-6. 
 192.  U.S. Patent No. 6,245,153 (filed August 8, 1999). 
 193.  Smith, supra note 5. 
 194.  U.S. Patent No. 10,632,167 (filed Nov. 3, 2017). 
 195.  U.S. Patent No. 10,632,167 (filed Nov. 3, 2017). 
 196.  Marinangeli, supra note 139, at 259. 
 197.  Id. at 265. 
 198.  Brenner v. Manson, 383 U.S. 519 (1966). 
 199.  Id. at 531-532. 
 200.  Id. at 535. 
 201.  35 U.S.C. § 101 (2019). 
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follows the presumption of credibility of source.202 Although current 
research appears to question the credibility of Mr. Gonzalez’s assertions, 
it is not the job of the patent examiners at the USPTO to conduct extensive 
research into the validity of utility claims.203 Rather, the USPTO “must 
treat as true a statement of fact made by an applicant in relation to an 
asserted utility.”204 To overcome this presumption, a significant amount 
of evidence would be necessary to prove that the original studies were so 
wrong that the patent should be invalidated.205 Because this evidence 
simply does not yet exist, it is unlikely that an attack on the credibility of 
the underlying utility of the ‘167 Patent would be sufficient for a court to 
invalidate the patent. 
A second argument against the ‘167 Patent’s validity is for lack of 
novelty, and in the alternative, for being obvious, over the traditional 
methods of producing panela that have been practiced for centuries.206 
Because of the ‘167 Patent’s narrowness and having already overcome 
similar rejections during patent prosecution, this argument is likely to 
fail.207 As mentioned above, the novelty standard requires prior art satisfy 
the strict identity standard to anticipate the claimed invention.208 
Therefore, for the ‘167 Patent to be invalidated for lack of novelty, it must 
be shown that the claimed method for producing the policosanol-rich 
sugarcane juice is identical to any current or former method of producing 
panela. 
At their core, the ‘167 Patent’s claims are made up of the following 
nine steps: (1) hand-cut raw sugarcane; (2) shred the unwashed sugarcane; 
(3) run the shredded sugarcane through a series of roller mills designed to 
extract the sugarcane juice from the stalks; (4) filter the resulting juice; 
(5) stabilize the pH of the filtered juice; (6) heat the stabilized juice; (7) 
clarify the heated juice via flocculation; (8) concentrate the sugar content 
via evaporation; and (9) extract the evaporated juice concentrate.209 When 
comparing these steps to the traditional process used in Colombia, there 
seems to be a strong case for anticipation. In both processes, sugarcane is 
hand-cut, subjected to a series of rollers and a pH management step, 
clarified via natural flocculants, heated, evaporated, and cooled.210  
Even though there are striking similarities between these two 
 
 202.  MUELLER, supra note 11, at 959. 
 203.  Id. at 497. 
 204.  Id. 
 205.  Id. at 959. Although not statutorily established, the standard of proof for the invalidity of an 
issued patent is “clear and convincing.” Id.  
 206.  See supra Part II.A. 
 207.  See supra Part II.D.3. 
 208.  MUELLER, supra note 11, at 242. 
 209.  U.S. Patent No. 10,632,167 (filed Nov. 3, 2017). 
 210.  Smith, supra note 5. 
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processes, the ‘167 Patent implements specific limitations within each 
step.211 These specific limitations include: (1) not cleaning the cut cane 
stalks; (2) heating the pH-stabilized juice without reaching a temperature 
that would evaporate policosanols; and (3) filtering the froth resulting 
from the use of flocculants during the clarification process and re-adding 
it to the juice.212 Further, the ‘167 Patent is based on the use of industrial 
technology.213 Conversely, the traditional method of panela production is 
much less specific.214 For example, the proper heating temperatures and 
evaporation steps of the traditional method are all performed manually 
and without specific ranges.215 While it is conceivable that at some point 
a Colombian trapiche has kept temperatures below seventy degrees 
Celsius, the total combination of policosanol-preserving steps has likely 
never been performed. Therefore, a lack of novelty argument is likely to 
fail. 
The final argument against the ‘167 Patent’s validity is that it would 
have been obvious to a PHOSITA to produce cane juice as claimed by the 
patent.216 The ‘167 Patent was originally rejected for obviousness, but the 
rejection was rescinded upon further argument by Mr. Gonzalez.217 Mr. 
Gonzalez was able to work around these rejections by identifying the ‘167 
Patent’s additional measures to preserve policosanols and the extensive 
testing performed to perfect those measures.218 Therefore, because the 
obviousness arguments have already been tried and reversed, this 
argument is not likely to prove invalidity. 
Ultimately, for the ‘167 Patent to be ruled invalid, the most persuasive 
argument is that the policosanols have no actual utility. Because the 
novelty and obviousness arguments have essentially been exhausted, it is 
unlikely they would prevail without the surfacing of additional relevant 
prior art. Luckily for Colombians, the validity of the ‘167 Patent should 
not cause alarm. 
B. The Effect of U.S. Patent No. 10,632,167 on the Colombian Panela 
Market 
While at first glance the ‘167 Patent may appear disastrous for the 
Colombian panela industry, it is unlikely to cause any changes. First, the 
 
 211.  U.S. Patent No. 10,632,167 (filed Nov. 3, 2017). 
 212.  Id. 
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 215.  See supra Part II.A. 
 216.  See supra Part II.B.2. 
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 218.  Amendment, supra note 181. 
21
Ostrowski: Trick or Treat? How a U.S. Patent Over a Method for Processing Su
Published by University of Cincinnati College of Law Scholarship and Publications,
686 UNIVERSITY OF CINCINNATI LAW REVIEW [VOL. 90 
exclusionary rights granted by a patent are limited by the geographic 
borders of the country in which it was issued.219 Second, the ‘167 Patent 
only prevents producers from processing sugarcane under the exact 
method claimed by the patent. Third, the Colombian government is not 
likely to allow a single entity to upend one of the most important 
industries within its borders. 
The exclusionary rights of patents are generally not enforced 
extraterritorially.220 Even if the ‘167 Patent is valid in the U.S., its 
exclusionary rights would not apply in Colombia unless a patent is also 
granted there.221 Given that only 0.4% of Colombian panela becomes 
destined for export, the 98% that is consumed domestically would be 
unaffected.222 
The ‘167 Patent’s claims and prosecution history reveal the impact the 
patent is likely to have on the Colombian panela industry. For the ‘167 
Patent to exclude panela producers, those producers would need to follow 
the patent exactly.223 Because the standard method of panela production 
does not incorporate the precise method detailed in the ‘167 Patent, 
traditional panela producers would not be liable for infringement. First, 
the panela produced in Colombian trapiches is typically a solid product, 
whereas the ‘167 Patent covers the production of a liquid.224 Second, Mr. 
Gonzalez did not file the ‘153 Patent in Colombia; the ‘153 Patent was a 
broader version of the current patent, so Mr. Gonzalez likely knew it 
would waste resources to file an application where the patent would not 
be granted or, at the very least, profitable.225  
Further, because the ‘167 Patent’s claims are narrow, if granted in 
Colombia, they are unlikely to cover traditional panela production. 
Colombian patent law does not recognize the doctrine of equivalents and 
proving literal infringement of the ‘167 Patent’s narrow claims would be 
a difficult task. 226 But, even if the patent is granted in Colombia and a 
Colombian court somehow finds that traditional panela production 
literally infringes the ‘167 Patent, the infringing producer would be able 
to claim prior user rights by pointing to panela’s extensive history, 
thereby avoiding sanctions.  
Lastly, the Colombian government would not allow a single entity to 
turn its panela industry upside down. Under Law 40, even current 
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producers of centrifugal sugar cannot fully intrude on the panela market 
when their own market becomes saturated.227 Panela producers are held 
to a high standard and are strictly regulated to maintain the over 350,000 
jobs that are directly and indirectly related to the industry.228 Therefore, 
even if Mr. Gonzalez is somehow able to enter the market alongside 
traditional trapiches, he would face strict regulations on the quantity of 
product he would be able to produce and business for the traditional 
trapiches would continue as usual.229 
IV. CONCLUSION 
In conclusion, the ‘167 Patent would likely be found valid if challenged 
in a U.S. court of law. The strongest argument against its validity is that 
it lacks utility because the Cuban studies that make up its basis of utility 
have questionable credibility.230 If challengers to the ‘167 Patent were to 
make this argument, they should produce additional studies to fully 
discredit the Cuban studies and prove that policosanols have neither the 
utility claimed nor any other use.231 
Fortunately for Colombians, the ‘167 Patent is unlikely to have any 
major impact on Colombia’s panela market regardless of whether the 
patent is valid. The scope of the ‘167 Patent’s claims is narrow and would 
only prevent panela producers from operating within very specific means. 
Further, because only 0.4% of Colombian panela is used for export, and 
because U.S. patents only prevent U.S. production and importation, the 
Colombian market will be virtually unaffected by the U.S. patent.232 
Colombians should therefore be unalarmed by the ‘167 Patent and its 
Colombian counterpart and continue to enjoy the regional delicacy. 
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